The persistence of replication-competent HIV-1 within latent cellular reservoirs constitutes the definitive barrier to a cure.While antiretroviral therapy suppresses active replication, it cannot engage transcriptionally silent proviruses. This review articulates a paradigm shift from systemic pharmacology to precision-targeted intervention, enabled by programmable nanomedicine. We examine the conceptual and material foundations of multifunctional nanovectors engineered to execute the sequential steps of "Shock & Kill"—latency reversal, immune engagement, and targeted cell elimination—within a single, spatiotemporally controlled system. These platforms offer a transformative solution to the core limitations of conventional approaches, promising to translate the Shock & Kill hypothesis from a blunt empiric strategy into an orchestrated therapeutic reality. Keywords : HIV cure,Latent reservoir,Shock and Kill,Nanomedicine, Targeted drug delivery, Multifunctional nanoparticles, Programmable release, Combinatorial therapy,Stimuli-responsive,Cell-specific targeting,Viral persistence,Lymphoid tissue, CD4+ T cells, Precision medicine, Translational research